SELLAS Life Sciences Group (SLS) Total Liabilities: 2011-2024
Historic Total Liabilities for SELLAS Life Sciences Group (SLS) over the last 9 years, with Sep 2024 value amounting to $10.6 million.
- SELLAS Life Sciences Group's Total Liabilities fell 10.91% to $10.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $10.6 million, marking a year-over-year decrease of 10.91%. This contributed to the annual value of $14.2 million for FY2023, which is 11.79% down from last year.
- Latest data reveals that SELLAS Life Sciences Group reported Total Liabilities of $10.6 million as of Q3 2024, which was down 13.05% from $12.2 million recorded in Q2 2024.
- Over the past 5 years, SELLAS Life Sciences Group's Total Liabilities peaked at $18.1 million during Q4 2020, and registered a low of $5.9 million during Q4 2021.
- Over the past 3 years, SELLAS Life Sciences Group's median Total Liabilities value was $13.7 million (recorded in 2023), while the average stood at $13.9 million.
- Per our database at Business Quant, SELLAS Life Sciences Group's Total Liabilities crashed by 67.23% in 2021 and then spiked by 171.46% in 2022.
- SELLAS Life Sciences Group's Total Liabilities (Quarterly) stood at $18.1 million in 2020, then slumped by 67.23% to $5.9 million in 2021, then spiked by 171.46% to $16.1 million in 2022, then dropped by 11.79% to $14.2 million in 2023, then decreased by 10.91% to $10.6 million in 2024.
- Its last three reported values are $10.6 million in Q3 2024, $12.2 million for Q2 2024, and $14.8 million during Q1 2024.